date:Jul 07, 2012
n traction in European and wider Asian markets, Aydogan said.
Germany will be one target within Europe, as itis one of the key EU markets for traditional herbal medicines and other herbal extracts. However, it is also one of the most difficult to enter because it is very rigid and highly regulated,he said.
Phytonet therefore wants to have a pre-submission meeting with the countrys drug authority BfArM to discuss requirements for market entry, he said, meanwhile the focus is on Eastern Europe